🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral GLP-1 pipeline overview — all agents in development Page 15

Oral GLP-1 pipeline overview — all agents in development

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 291 replies 50,237 viewsPage 15 of 20
SkepticalSean
Member
98
345
Jan 2025
Maine
Apr 18, 2024 at 12:18 AM#71
Dr.AddMedPHL said:
Say what you would expect to see if you were wrong, before you look.

Agreed, and the size of the effect matters as much as its existence. Something real and small gets treated here as though it were real and decisive.

43 16DerekSJ_a1c, paige_pharma, emma_london and 40 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Apr 18, 2024 at 10:30 PM#72
Dr.AddMedPHL said:
Say what you would expect to see if you were wrong, before you look.

This is exactly what I could not find anywhere else.

44 17alex_tucson, kevin_tulsa, Dr.PainCLE and 41 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Apr 19, 2024 at 8:42 PM#73

Adding the clinical framing, because it changes how the question reads. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Apr 19, 2024 at 9:42 PM
45 18adam_van, Dr.SurgeonPGH, rachel_ABQ and 42 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
tampaLisa73
Member
312
1,456
Oct 2024
Tampa, FL
Apr 20, 2024 at 6:53 PM#74

Old thread, but it comes up first when you search for this, so it is worth updating. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

46 19mike.trainer_LA, sarah_nash92, FitDadDave and 43 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Apr 21, 2024 at 5:04 PM#75
paige_pharma said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

There is a second half to this that has not been said yet. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

47 20MikeNYC_runner and 44 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register